Biotech Servier acquires potential treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder September 8, 2025
Biotech Antibody Discovery Market worth US$3.54 billion by 2030 with 13.3% CAGR | MarketsandMarkets™ September 7, 2025
Biotech Huadong Medicine Announces Positive Preliminary Results from a Phase Ⅰ study of HDM2005, a ROR1-Targeting ADC September 6, 2025
Biotech SOPHiA GENETICS and Jessa Ziekenhuis Announce Precision Oncology Partnership from the European Congress of Pathology September 5, 2025
Biotech Nektar Therapeutics to Participate in Two Investor Conferences in September September 4, 2025
Biotech Dr. Sunil Chandran Rejoins Amyris as Chief Technology Officer to Meet Growing Customer Demand for Innovative and Renewable Biological Chemistry September 3, 2025
Biotech Ascletis to Present 28-day Multiple Ascending Dose Study Results of Oral Small Molecule GLP-1R Agonist ASC30 at the 61st European Association for the Study of Diabetes (EASD) Annual Meeting September 2, 2025
Biotech CMEF 2025: Promoting Holistic and High-Quality Development of Medical and Health Industry September 1, 2025
Biotech US FDA approves Leqembi® IQKLIK ™ (lecanemab-irmb) subcutaneous injection for maintenance dosing for the treatment of early Alzheimer’s disease August 31, 2025
Search
Biotech
September 8, 2025
September 7, 2025
September 6, 2025
September 5, 2025
September 4, 2025
September 3, 2025
September 2, 2025
September 1, 2025
August 31, 2025
August 30, 2025
